Biocom’s 8th Annual Global Life Science Partnering Conference : 2018
Algomedix will be holding partnering meetings at Biocom’s 8th Annual Global Life Science Partnering Conference, February 28-March 1, 2018 in La Jolla, California.
J.P. Morgan Healthcare Conference 2018
Algomedix will be attending the JP Morgan Healthcare Conference in San Francisco, California from Jan 8-11th, 2018.
Precision Medicine and Ion Channel Retreat
Algomedix presents at the Precision Medicine and Ion Channel Retreat in 2017 in Vancouver, Canada. Dr. Herz will speak on “Development of a Novel Class of TRPA1 Antagonists as Effective Analgesic Drugs in Multiple Models of Neuropathic Pain” on August 8-11th, 2017.
LSIW: Next-Generation Therapeutics for the Treatment of Pain
Algomedix will present at a meeting: Next-Generation Therapeutics for the Treatment of Pain, a Life Science Washington Special Program, April 27, 2017. Dr. Herz will describe progress in the development of TRPA1 antagonists for the treatment of chronic pain.
Cavendish Global Innovation Partner
Algomedix, a Cavendish Global Innovation Partner, presents at the 3rd San Diego Health Impact Forum in San Diego, California, February 6-8th, 2017.
World Congress on Pain
Algomedix will be attending the World Congress on Pain, October 26-30th, 2016, to be held in Yokohama, Japan.